NEW YORK--(BUSINESS WIRE)--World Liberty Financial today announced that WLTC Holdings LLC filed a de novo application to the Office of the Comptroller of the Currency (OCC) to establish World Liberty ...

JavaScript projects should use modern tools like Node.js, AI tools, and TypeScript to align with industry trends.Building ...

Clark Atlanta got more first time enrollment applications than UGA! Weight-loss drugs draw thousands of lawsuits alleging serious harm Republican senator shifts Trump insult toward Kristi Noem, ...

A popular California program designed to help people buy their first home is making a comeback. California's Dream For All program is reopening applications next month, offering down payment ...

SACRAMENTO — The California Housing Finance Agency’s Dream For All Shared Appreciation Loan program will begin accepting applications for down payment assistance on February 24. The life-changing down ...

ESTERO, FLORIDA / ACCESS Newswire / January 20, 2026 / Aspire Biopharma Holdings, Inc. (ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

Ilya Lichtenstein, who was sentenced to five years in prison in November 2024 after pleading guilty to charges tied to the 2016 Bitfinex cryptocurrency exchange hack, was released from prison after ...

The Swedish government has received an application for state aid to support proposals for either five GE Vernova Hitachi BWRX-300 reactors or three Rolls-Royce SMRs to provide about 1500 MW capacity ...

Union Pacific and Norfolk Southern’s growth-oriented merger argument remains sound, but the bid-ask spread on competitive concessions remains unknown until the rails respond. Downstream, we view today ...

nChroma Bio Receives Authorization of Clinical Trial Application to Initiate First-in-Human Study for Epigenetic Silencer CRMA-1001 for the Treatment of Chronic Hepatitis B First CTA authorization ...